The methods and results of uterine body cancer: a twenty-year experience of treatments at the Tbilisi Oncological Center

other public-domain-us
View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-08-08

This study reviewed 1100 endometrial cancer cases from 1968-1987, finding that surgical treatment, particularly hysterectomy and adnexectomy, yielded 5-year survival rates from 40.8% to 88.1% based on tumor size and myometrial involvement.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In the period 1968-1987 at the Oncological Scientific Center of Tbilisi 1100 Endometrial Cancer were observed. All patients were treated surgically and in particular 89.9% cases with total hysterectomy and adnexectomy; 9.8% with hysterectomy, adnexectomy and lymphadenectomy; 0.3% with Wertheim's operation. The Author suggests a pathological staging system with in the first stage (cancer limited to the uterus) in order to better select the treatment and prognosis of patients. According to his classification 5 years survival was 88.1% when tumour was absent in the operative specimen; 82.6% when the tumor was less 2 cm; 67.5% for tumour more than 2 cm; 60.3% when less than half of the myometrium was involved and 40.8% with more than half of the myometrium. The Author confirms the validity of surgical therapy in endometrial cancer eventually associated with hormonal and/or radiotherapy for the cases more at risk.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Carcinoma, Squamous Cell Endometriosis Uterine Neoplasms Adenocarcinoma Carcinoma, Squamous Cell Endometriosis Evaluation Studies as Topic Female Humans Retrospective Studies USSR Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-06T09:34:12.023084+00:00
pubmed
last seen: 2026-05-13T22:09:15.954262+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine